Muñoz J J, De Salamanca R E, Diaz-Obregón C, Timoneda F L
Porphyria Research Unit, Hospital Universitario San Carlos, Madrid, Spain.
Br J Clin Pharmacol. 1990 Jun;29(6):763-5. doi: 10.1111/j.1365-2125.1990.tb03699.x.
Steady state metabolite/parent drug plasma ratios were measured in 15 epileptic patients on carbamazepine (CBZ) monotherapy and in seven patients treated with CBZ and clobazam (CLB). CBZ plasma concentrations did not differ between the two groups but patients also treated with CLB exhibited higher concentrations of CBZ-10,11-epoxide (CBZ-E) and trans-10,11-dihydro-10,11-dihydroxy-CBZ (CBZ-T). Ratios between all of the metabolites of CBZ and the parent compound were higher in patients on polytherapy but the ratio between metabolites was not different. CLB comedication causes a moderate increase (about 1.5-fold) in CBZ metabolism, probably by inducing its epoxidation.
在15例接受卡马西平(CBZ)单药治疗的癫痫患者和7例接受CBZ与氯巴占(CLB)联合治疗的患者中测量了稳态代谢物/母体药物血浆比率。两组患者的CBZ血浆浓度无差异,但同时接受CLB治疗的患者表现出更高浓度的CBZ - 10,11 - 环氧化物(CBZ - E)和反式 - 10,11 - 二氢 - 10,11 - 二羟基 - CBZ(CBZ - T)。联合治疗患者中CBZ所有代谢物与母体化合物之间的比率更高,但代谢物之间的比率没有差异。CLB联合用药可能通过诱导CBZ环氧化使CBZ代谢适度增加(约1.5倍)。